Exome sequence capture and massively parallel sequencing can be combined to achieve inexpensive and rapid global analyses of the functional sections of the genome. The difficulties of working with relatively small quantities of genetic material, as may be necessary when sharing tumor biopsies between collaborators for instance, can be overcome using whole genome amplification. However, the potential drawbacks of using a whole genome amplification technology based on random primers in combination with sequence capture followed by massively parallel sequencing have not yet been examined in detail, especially in the context of mutation discovery in tumor material. In this work, we compare mutations detected in sequence data for unamplified DNA...
Abstract The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated co...
AbstractPersonalized cancer treatment requires molecular characterization of individual tumor biopsi...
The clinical management of patients with cancer of unknown primary (CUP) is hampered by the absence ...
<div><p>Exome sequence capture and massively parallel sequencing can be combined to achieve inexpens...
Exome sequence capture and massively parallel sequencing can be combined to achieve inexpensive and ...
The concept of Whole Genome Amplification is something that has arisen in the past few years as modi...
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Advances in next generation sequencing technologies provide approaches to comprehensively determine ...
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
It is well established that genomic alterations play an essential role in oncogenesis, disease progr...
Molecular genotyping has important biomedical and forensic applications. However, limiting amounts o...
Massively parallel sequencing has permitted an unprecedented examination of the cancer exome, leadin...
Abstract The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated co...
AbstractPersonalized cancer treatment requires molecular characterization of individual tumor biopsi...
The clinical management of patients with cancer of unknown primary (CUP) is hampered by the absence ...
<div><p>Exome sequence capture and massively parallel sequencing can be combined to achieve inexpens...
Exome sequence capture and massively parallel sequencing can be combined to achieve inexpensive and ...
The concept of Whole Genome Amplification is something that has arisen in the past few years as modi...
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Advances in next generation sequencing technologies provide approaches to comprehensively determine ...
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
It is well established that genomic alterations play an essential role in oncogenesis, disease progr...
Molecular genotyping has important biomedical and forensic applications. However, limiting amounts o...
Massively parallel sequencing has permitted an unprecedented examination of the cancer exome, leadin...
Abstract The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated co...
AbstractPersonalized cancer treatment requires molecular characterization of individual tumor biopsi...
The clinical management of patients with cancer of unknown primary (CUP) is hampered by the absence ...